GLA Antikörper (AA 150-429)
-
- Target Alle GLA Antikörper anzeigen
- GLA (Galactosidase, alpha (GLA))
-
Bindungsspezifität
- AA 150-429
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GLA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF)
- Sequenz
- GYYDIDAQTF ADWGVDLLKF DGCYCDSLEN LADGYKHMSL ALNRTGRSIV YSCEWPLYMW PFQKPNYTEI RQYCNHWRNF ADIDDSWKSI KSILDWTSFN QERIVDVAGP GGWNDPDMLV IGNFGLSWNQ QVTQMALWAI MAAPLFMSND LRHISPQAKA LLQDKDVIAI NQDPLGKQGY QLRQGDNFEV WERPLSGLAW AVAMINRQEI GGPRSYTIAV ASLGKGVACN PACFITQLLP VKRKLGFYEW TSRLRSHINP TGTVLLQLEN TMQMSLKDLL
- Kreuzreaktivität
- Human, Maus
- Produktmerkmale
- Polyclonal Antibodies
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 150-429 of human Galactosidase alpha (Galactosidase alpha (GLA)) (NP_000160.1).
- Isotyp
- IgG
- Top Product
- Discover our top product GLA Primärantikörper
-
anti-Galactosidase, alpha (GLA) (AA 81-429) antibody
GLA Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 81-429) antibodyGLA Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C6 unconjugated
anti-Galactosidase, alpha (GLA) antibodyKO Validated GLA Reaktivität: Human WB, IP, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 1-80) antibodyGLA Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 83-112), (N-Term) antibodyGLA Reaktivität: Human WB, FACS, IF, IHC (p) Wirt: Kaninchen Polyclonal RB19115 unconjugated
anti-Galactosidase, alpha (GLA) (AA 147-371) antibodyGLA Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 1-429) antibodyGLA Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 32-429) antibodyGLA Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 101-200) antibodyGLA Reaktivität: Human, Maus, Ratte WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 1-429) antibodyGLA Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
- WB,1:500 - 1:2000,IF,1:50 - 1:100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- GLA (Galactosidase, alpha (GLA))
- Andere Bezeichnung
- GLA (GLA Produkte)
- Hintergrund
- This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties.,GLA,GALA,Cardiovascular,Blood,Blood Cell Antigens,GLA
- Molekulargewicht
- 48 kDa
- Gen-ID
- 2717
- UniProt
- P06280
- Pathways
- SARS-CoV-2 Protein Interaktom
-
